{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/PSTV/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T10:12:51.138Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":11696,"canonical_name":"PLUS THERAPEUTICS, INC.","cik":"0001095981","uei":null,"lei":null,"duns":null,"ticker":"PSTV"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":64},"count":64,"timeline":[{"ts":"2026-10-02","kind":"sec.filing","form_type":"8-K","title":"8-K — CERENOME, INC. — 2026-10-02","url_slug":"/sec/cik-0001095981/8-k/0001193125-26-411259","accession_number":"0001193125-26-411259","importance":35},{"ts":"2026-10-01","kind":"sec.filing","form_type":"4","title":"4 — CERENOME, INC. — 2026-10-01","url_slug":"/sec/cik-0001095981/4/0001193125-26-409855","accession_number":"0001193125-26-409855","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"4","title":"4 — CERENOME, INC. — 2026-10-01","url_slug":"/sec/cik-0001095981/4/0001193125-26-409856","accession_number":"0001193125-26-409856","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"4","title":"4 — CERENOME, INC. — 2026-10-01","url_slug":"/sec/cik-0001095981/4/0001193125-26-409857","accession_number":"0001193125-26-409857","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"4","title":"4 — CERENOME, INC. — 2026-10-01","url_slug":"/sec/cik-0001095981/4/0001193125-26-409858","accession_number":"0001193125-26-409858","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"4","title":"4 — CERENOME, INC. — 2026-10-01","url_slug":"/sec/cik-0001095981/4/0001193125-26-409859","accession_number":"0001193125-26-409859","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"4","title":"4 — CERENOME, INC. — 2026-10-01","url_slug":"/sec/cik-0001095981/4/0001193125-26-409860","accession_number":"0001193125-26-409860","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"4","title":"4 — CERENOME, INC. — 2026-10-01","url_slug":"/sec/cik-0001095981/4/0001193125-26-409861","accession_number":"0001193125-26-409861","importance":30},{"ts":"2026-10-01","kind":"sec.insider.921","reporter":"van Es-Johansson An","title":null,"shares":921,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-10-01","kind":"sec.insider.921","reporter":"Hawkins Richard J","title":null,"shares":921,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-10-01","kind":"sec.insider.921","reporter":"Clowes Howard","title":null,"shares":921,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-10-01","kind":"sec.insider.1533","reporter":"Sims Andrew John Hugh MacIntyre","title":"Chief Financial Officer","shares":1533,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-10-01","kind":"sec.insider.1165","reporter":"Sims Andrew John Hugh MacIntyre","title":"Chief Financial Officer","shares":1165,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-10-01","kind":"sec.insider.287","reporter":"Sims Andrew John Hugh MacIntyre","title":"Chief Financial Officer","shares":287,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-10-01","kind":"sec.insider.921","reporter":"ANDREWS RONALD ASBURY","title":null,"shares":921,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-10-01","kind":"sec.insider.6387","reporter":"HEDRICK MARC H","title":"Chief Executive Officer","shares":6387,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-10-01","kind":"sec.insider.8066","reporter":"HEDRICK MARC H","title":"Chief Executive Officer","shares":8066,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-10-01","kind":"sec.insider.1986","reporter":"HEDRICK MARC H","title":"Chief Executive Officer","shares":1986,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-10-01","kind":"sec.insider.921","reporter":"Guse Kyle","title":null,"shares":921,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-09-18","kind":"sec.filing","form_type":"D","title":"D — CERENOME, INC. — 2026-09-18","url_slug":"/sec/cik-0001095981/d/0001193125-26-395734","accession_number":"0001193125-26-395734","importance":30},{"ts":"2026-09-10","kind":"sec.filing","form_type":"8-K","title":"8-K — CERENOME, INC. — 2026-09-10","url_slug":"/sec/cik-0001095981/8-k/0001193125-26-387267","accession_number":"0001193125-26-387267","importance":35},{"ts":"2026-08-14","kind":"sec.filing","form_type":"10-Q","title":"10-Q — CERENOME, INC. — 2026-08-14","url_slug":"/sec/cik-0001095981/10-q/0001193125-26-352444","accession_number":"0001193125-26-352444","importance":45},{"ts":"2026-08-14","kind":"sec.filing","form_type":"8-K","title":"8-K — CERENOME, INC. — 2026-08-14","url_slug":"/sec/cik-0001095981/8-k/0001193125-26-352346","accession_number":"0001193125-26-352346","importance":35},{"ts":"2026-08-04","kind":"sec.filing","form_type":"8-K","title":"8-K — CERENOME, INC. — 2026-08-04","url_slug":"/sec/cik-0001095981/8-k/0001193125-26-332939","accession_number":"0001193125-26-332939","importance":35},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — PLUS THERAPEUTICS, INC. — 2026-07-01","url_slug":"/sec/cik-0001095981/4/0001193125-26-292648","accession_number":"0001193125-26-292648","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — PLUS THERAPEUTICS, INC. — 2026-07-01","url_slug":"/sec/cik-0001095981/4/0001193125-26-292649","accession_number":"0001193125-26-292649","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — PLUS THERAPEUTICS, INC. — 2026-07-01","url_slug":"/sec/cik-0001095981/4/0001193125-26-292654","accession_number":"0001193125-26-292654","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — PLUS THERAPEUTICS, INC. — 2026-07-01","url_slug":"/sec/cik-0001095981/4/0001193125-26-292639","accession_number":"0001193125-26-292639","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — PLUS THERAPEUTICS, INC. — 2026-07-01","url_slug":"/sec/cik-0001095981/4/0001193125-26-292642","accession_number":"0001193125-26-292642","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — PLUS THERAPEUTICS, INC. — 2026-07-01","url_slug":"/sec/cik-0001095981/4/0001193125-26-292643","accession_number":"0001193125-26-292643","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — PLUS THERAPEUTICS, INC. — 2026-07-01","url_slug":"/sec/cik-0001095981/4/0001193125-26-292644","accession_number":"0001193125-26-292644","importance":30},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"Sims Andrew John Hugh MacIntyre","title":"Chief Financial Officer","shares":1533,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"Sims Andrew John Hugh MacIntyre","title":"Chief Financial Officer","shares":1165,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"Sims Andrew John Hugh MacIntyre","title":"Chief Financial Officer","shares":287,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"Hawkins Richard J","title":null,"shares":922,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"ANDREWS RONALD ASBURY","title":null,"shares":922,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"Clowes Howard","title":null,"shares":922,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"HEDRICK MARC H","title":"Chief Executive Officer","shares":6387,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"HEDRICK MARC H","title":"Chief Executive Officer","shares":8066,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"HEDRICK MARC H","title":"Chief Executive Officer","shares":1986,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"van Es-Johansson An","title":null,"shares":922,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"HEDRICK MARC H","title":"Chief Executive Officer","shares":6387,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"HEDRICK MARC H","title":"Chief Executive Officer","shares":8066,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"HEDRICK MARC H","title":"Chief Executive Officer","shares":1986,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"Guse Kyle","title":null,"shares":922,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-18","kind":"sec.filing","form_type":"S-8","title":"S-8 — PLUS THERAPEUTICS, INC. — 2026-06-18","url_slug":"/sec/cik-0001095981/s-8/0001193125-26-275955","accession_number":"0001193125-26-275955","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"8-K","title":"8-K — PLUS THERAPEUTICS, INC. — 2026-06-05","url_slug":"/sec/cik-0001095981/8-k/0001193125-26-259703","accession_number":"0001193125-26-259703","importance":35},{"ts":"2026-06-05","kind":"sec.filing","form_type":"CORRESP","title":"CORRESP — PLUS THERAPEUTICS, INC. — 2026-06-05","url_slug":"/sec/cik-0001095981/corresp/0001193125-26-258709","accession_number":"0001193125-26-258709","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — PLUS THERAPEUTICS, INC. — 2026-06-05","url_slug":"/sec/cik-0001095981/effect/9999999995-26-001913","accession_number":"9999999995-26-001913","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"S-3/A","title":"S-3/A — PLUS THERAPEUTICS, INC. — 2026-06-05","url_slug":"/sec/cik-0001095981/s-3-a/0001193125-26-258388","accession_number":"0001193125-26-258388","importance":30},{"ts":"2026-06-04","kind":"sec.filing","form_type":"UPLOAD","title":"UPLOAD — CERENOME, INC. — 2026-06-04","url_slug":"/sec/cik-0001095981/upload/0000000000-26-005651","accession_number":"0000000000-26-005651","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"S-3","title":"S-3 — PLUS THERAPEUTICS, INC. — 2026-06-02","url_slug":"/sec/cik-0001095981/s-3/0001193125-26-252119","accession_number":"0001193125-26-252119","importance":30},{"ts":"2026-05-18","kind":"sec.filing","form_type":"4","title":"4 — PLUS THERAPEUTICS, INC. — 2026-05-18","url_slug":"/sec/cik-0001095981/4/0001193125-26-228917","accession_number":"0001193125-26-228917","importance":30},{"ts":"2026-05-18","kind":"sec.filing","form_type":"4","title":"4 — PLUS THERAPEUTICS, INC. — 2026-05-18","url_slug":"/sec/cik-0001095981/4/0001193125-26-228919","accession_number":"0001193125-26-228919","importance":30},{"ts":"2026-05-18","kind":"sec.filing","form_type":"4","title":"4 — PLUS THERAPEUTICS, INC. — 2026-05-18","url_slug":"/sec/cik-0001095981/4/0001193125-26-228922","accession_number":"0001193125-26-228922","importance":30},{"ts":"2026-05-18","kind":"sec.filing","form_type":"4","title":"4 — PLUS THERAPEUTICS, INC. — 2026-05-18","url_slug":"/sec/cik-0001095981/4/0001193125-26-228926","accession_number":"0001193125-26-228926","importance":30},{"ts":"2026-05-18","kind":"sec.filing","form_type":"4","title":"4 — PLUS THERAPEUTICS, INC. — 2026-05-18","url_slug":"/sec/cik-0001095981/4/0001193125-26-228929","accession_number":"0001193125-26-228929","importance":30},{"ts":"2026-05-18","kind":"sec.filing","form_type":"4","title":"4 — PLUS THERAPEUTICS, INC. — 2026-05-18","url_slug":"/sec/cik-0001095981/4/0001193125-26-228930","accession_number":"0001193125-26-228930","importance":30},{"ts":"2026-05-18","kind":"sec.filing","form_type":"4","title":"4 — PLUS THERAPEUTICS, INC. — 2026-05-18","url_slug":"/sec/cik-0001095981/4/0001193125-26-228933","accession_number":"0001193125-26-228933","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — PLUS THERAPEUTICS, INC. — 2026-05-15","url_slug":"/sec/cik-0001095981/schedule-13g/0000919574-26-003205","accession_number":"0000919574-26-003205","importance":55},{"ts":"2026-05-15","kind":"sec.filing","form_type":"10-Q","title":"10-Q — PLUS THERAPEUTICS, INC. — 2026-05-15","url_slug":"/sec/cik-0001095981/10-q/0001193125-26-226978","accession_number":"0001193125-26-226978","importance":45},{"ts":"2026-05-15","kind":"sec.filing","form_type":"8-K","title":"8-K — PLUS THERAPEUTICS, INC. — 2026-05-15","url_slug":"/sec/cik-0001095981/8-k/0001193125-26-226747","accession_number":"0001193125-26-226747","importance":35},{"ts":"2026-05-15","kind":"sec.filing","form_type":"8-K","title":"8-K — PLUS THERAPEUTICS, INC. — 2026-05-15","url_slug":"/sec/cik-0001095981/8-k/0001193125-26-227059","accession_number":"0001193125-26-227059","importance":35},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — PLUS THERAPEUTICS, INC. — 2026-05-15","url_slug":"/sec/cik-0001095981/schedule-13g-a/0001649553-26-000057","accession_number":"0001649553-26-000057","importance":30}]}